Free Trial

Chemours (CC) News Today

Chemours logo
$14.46 +0.02 (+0.10%)
As of 12:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
The Chemours Company stock logo
Walnut Level Capital LLC Grows Position in The Chemours Company (NYSE:CC)
Walnut Level Capital LLC raised its holdings in The Chemours Company (NYSE:CC - Free Report) by 60.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 80,000 shares of the specialty chemicals
The Chemours Company stock logo
Chemours (NYSE:CC) Stock Price Down 5.4% - Here's What Happened
Chemours (NYSE:CC) Stock Price Down 5.4% - Should You Sell?
The Chemours Company stock logo
Intech Investment Management LLC Grows Position in The Chemours Company (NYSE:CC)
Intech Investment Management LLC boosted its stake in shares of The Chemours Company (NYSE:CC - Free Report) by 639.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 135,790 shares of the specialty chemicals company's stock after
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Shares Purchased by Advisors Asset Management Inc.
Advisors Asset Management Inc. boosted its position in The Chemours Company (NYSE:CC - Free Report) by 146.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 235,238 shares of the specialty chemicals company's stock afte
The Chemours Company stock logo
Charles Schwab Investment Management Inc. Boosts Stock Holdings in The Chemours Company (NYSE:CC)
Charles Schwab Investment Management Inc. grew its stake in shares of The Chemours Company (NYSE:CC - Free Report) by 6.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,302,272 sh
Analysts Set The Chemours Company (NYSE:CC) PT at $23.11
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Receives Average Recommendation of "Hold" from Analysts
The Chemours Company (NYSE:CC - Get Free Report) has earned a consensus rating of "Hold" from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1
The Chemours Company stock logo
Chemours (NYSE:CC) Sets New 52-Week Low - Should You Sell?
Chemours (NYSE:CC) Reaches New 52-Week Low - Time to Sell?
The Chemours Company stock logo
Channing Capital Management LLC Makes New $4.70 Million Investment in The Chemours Company (NYSE:CC)
Channing Capital Management LLC acquired a new stake in shares of The Chemours Company (NYSE:CC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 278,144 shares of the specialty chemicals company's stock
The Chemours Company stock logo
19,790 Shares in The Chemours Company (NYSE:CC) Purchased by Proficio Capital Partners LLC
Proficio Capital Partners LLC bought a new stake in The Chemours Company (NYSE:CC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 19,790 shares of the specialty chemicals company's stock, va
The Chemours Company stock logo
Bank of New York Mellon Corp Has $17.75 Million Holdings in The Chemours Company (NYSE:CC)
Bank of New York Mellon Corp lessened its stake in The Chemours Company (NYSE:CC - Free Report) by 29.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,049,985 shares of the specialty c
The Chemours Company stock logo
Zacks Research Has Negative Outlook of Chemours Q1 Earnings
The Chemours Company (NYSE:CC - Free Report) - Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for Chemours in a research report issued on Monday, March 3rd. Zacks Research analyst R. Department now expects that the specialty chemicals company will post earnings of $0.1
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Shares Sold by M&T Bank Corp
M&T Bank Corp lowered its stake in shares of The Chemours Company (NYSE:CC - Free Report) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 487,645 shares of the specialty chemicals company's
The Chemours Company stock logo
Zacks Research Issues Negative Outlook for Chemours Earnings
The Chemours Company (NYSE:CC - Free Report) - Equities research analysts at Zacks Research cut their Q2 2025 earnings per share (EPS) estimates for Chemours in a report released on Monday, March 3rd. Zacks Research analyst R. Department now forecasts that the specialty chemicals company will pos
The Chemours Company stock logo
Chemours (NYSE:CC) Reaches New 52-Week Low - Time to Sell?
Chemours (NYSE:CC) Reaches New 12-Month Low - What's Next?
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Shares Purchased by LGT Fund Management Co Ltd.
LGT Fund Management Co Ltd. lifted its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 12.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 215,481 shares of the specialty chemicals company's stock
The Chemours Company stock logo
Y Intercept Hong Kong Ltd Takes Position in The Chemours Company (NYSE:CC)
Y Intercept Hong Kong Ltd bought a new position in shares of The Chemours Company (NYSE:CC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 58,908 shares of the specialty chemicals com
The Chemours Company stock logo
Chemours (NYSE:CC) Sets New 52-Week Low Following Analyst Downgrade
Chemours (NYSE:CC) Reaches New 1-Year Low Following Analyst Downgrade
Barclays Remains a Hold on Chemours Company (CC)
Chemours price target lowered to $19 from $23 at Barclays
The Chemours Company stock logo
Chemours (NYSE:CC) Price Target Cut to $19.00 by Analysts at Barclays
Barclays cut their target price on Chemours from $23.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Monday.
The Chemours Company stock logo
Bryn Mawr Capital Management LLC Sells 23,709 Shares of The Chemours Company (NYSE:CC)
Bryn Mawr Capital Management LLC trimmed its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 89.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,756 shares of the specialty chemicals company's stock
The Chemours Company stock logo
Strategic Financial Concepts LLC Acquires Shares of 21,135 The Chemours Company (NYSE:CC)
Strategic Financial Concepts LLC acquired a new stake in The Chemours Company (NYSE:CC - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 21,135 shares of the specialty chemicals company's stock, valued at a
The Chemours Company stock logo
BMO Capital Markets Issues Pessimistic Forecast for Chemours (NYSE:CC) Stock Price
BMO Capital Markets reduced their target price on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research report on Wednesday.
The Chemours Company stock logo
Chemours (NYSE:CC) Shares Gap Down - Time to Sell?
Chemours (NYSE:CC) Shares Gap Down - Here's What Happened
The Chemours Company stock logo
The Chemours Company (NYSE:CC) Declares $0.25 Quarterly Dividend
The Chemours Company (NYSE:CC) declared a quarterly dividend on Tuesday, February 18th. Stockholders of record on Friday, February 28th will be paid a dividend of 0.25 per share by the specialty chemicals company on Friday, March 14th. This represents a $1.00 annualized dividend and a dividend yield of 5.72%. The ex-dividend date is Friday, February 28th.
The Chemours Company stock logo
Chemours (NYSE:CC) Issues Earnings Results, Beats Estimates By $0.01 EPS
Chemours (NYSE:CC - Get Free Report) released its quarterly earnings data on Tuesday. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. Chemours had a return on equity of 29.48% and a net margin of 1.34%.
Chemours launches Ti-Pure TS-6706
The Long-Term Upside For Chemours Company After Q4 2024
The Chemours Company stock logo
Peregrine Capital Management LLC Takes $5.73 Million Position in The Chemours Company (NYSE:CC)
Peregrine Capital Management LLC acquired a new position in shares of The Chemours Company (NYSE:CC - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 339,138 shares of the specialty chemicals c
Remove Ads
Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Related Videos

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

CC Media Mentions By Week

CC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CC
News Sentiment

0.73

0.57

Average
Basic Materials
News Sentiment

CC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CC Articles
This Week

6

8

CC Articles
Average Week

Remove Ads
Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:CC) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners